SlideShare a Scribd company logo
1 of 13
Download to read offline
SUV’s - A Brief Overview of Silly Useless Values.

 Todd Charge
 Senior Technologist
 Nuclear Medicine and PET Centre
 Hunter Health Imaging Service




                                   Hunter Health Imaging Service
Standardised Uptake Values



 Quantification has always held a pervasive
          allure for Nuclear Medicine.
 There is a sense that anything that can be
             quantified should be.

         J.W. Keyes Jr. PET Centre North Carolina USA
         Journal Nuclear Medicine 1995; 36:1836-1839




                                            Hunter Health Imaging Service
What are SUV’s?

   A measure of FDG uptake as a function of
    time
   Quantitative evaluation of tumour
    metabolism
   Often used as a measure of malignancy vs.
    benignancy of lesion




                                Hunter Health Imaging Service
Standardised Uptake Value




Data courtesy Mount Vernon Hospital




                                      Hunter Health Imaging Service
Standardised Uptake Value
    Pre Treatment   Post Treatment




     SUV = 18            SUV = 4
                        Hunter Health Imaging Service
Standardised Uptake Value



                  C /(T )
       SUV =
             dose/bodyweight

   Where C/(T) = FDG concentration in tissue
    at time T



                               Hunter Health Imaging Service
Standardised Uptake Value

   Tracer concentration is usually determined
    from the image pixel that shows the highest
    lesion activity
   Average concentration was once used but
    is not routinely in use now




                                Hunter Health Imaging Service
Assumptions of SUV’s

   Negligible free FDG in tissue at time of PET
    scan
   Equilibrium reached between plasma and
    free FDG in tissue
   All tissues are affected in the same way by
    glucose levels




                                 Hunter Health Imaging Service
Variables Influencing SUV’s
   Large number of variables which need to be
    taken into account.
   Patient size
   Measurement times
   Plasma Glucose
   ROI
   Partial Volume Effect
   Camera specifications


                                Hunter Health Imaging Service
Summary
   Use of Lean Body Mass instead of true
    weight
   Take plasma glucose levels into account,
    tumour type & possible treatment effects
   Standardise uptake time, attenuation
    correction, scatter correction and filtering
   Consider ROI placement and use of max
    pixel



                                  Hunter Health Imaging Service
Summary

   Only use SUV within institution and even
    camera specific
   Be careful when using SUV threshold to
    distinguish tumour from normal tissue
   Consider SUV in conjunction with a
    subjective analysis of a lesion.




                                Hunter Health Imaging Service
Summary



   Overall, recognise SUV’s for what they are:


     A helpful clue, but not the final answer.




                                 Hunter Health Imaging Service
References


   DiChiro G, Brooks RA. “PET quantitation: Blessing and Curse.” J Nucl Med
    1988:29;1603-1604
   S Meikle “Quantitative Methods and Factors Affecting SUV Calculation”
    ANZSNM PET Workshop 2003
   JW Keyes “SUV: Standard Uptake or Silly Useless Value?” J Nucl Med
    36:1836-1839, 1995




                                                     Hunter Health Imaging Service

More Related Content

What's hot

Principles and application of PET CT & PET MR
Principles and application of PET CT & PET MRPrinciples and application of PET CT & PET MR
Principles and application of PET CT & PET MR
charusmita chaudhary
 
4D Scan and Respiratory Gating
4D Scan and Respiratory Gating4D Scan and Respiratory Gating
4D Scan and Respiratory Gating
Kothanda Raman
 

What's hot (20)

Plan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr KiranPlan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr Kiran
 
Image guided radiation therapy (IGRT)
Image guided radiation therapy (IGRT)Image guided radiation therapy (IGRT)
Image guided radiation therapy (IGRT)
 
Principles and application of PET CT & PET MR
Principles and application of PET CT & PET MRPrinciples and application of PET CT & PET MR
Principles and application of PET CT & PET MR
 
Radiation therapy in prostate cancer
Radiation therapy in prostate cancer Radiation therapy in prostate cancer
Radiation therapy in prostate cancer
 
The principles of head and neck PET/CT
The principles of head and neck PET/CTThe principles of head and neck PET/CT
The principles of head and neck PET/CT
 
Magnetic resonance (mr) spectroscopy
Magnetic resonance (mr) spectroscopyMagnetic resonance (mr) spectroscopy
Magnetic resonance (mr) spectroscopy
 
CTDI (Computed Tomography Dose Index
CTDI (Computed Tomography Dose IndexCTDI (Computed Tomography Dose Index
CTDI (Computed Tomography Dose Index
 
Cancer imaging
Cancer imagingCancer imaging
Cancer imaging
 
HIPPOCAMPUS TARGET DELINEATION
HIPPOCAMPUS TARGET DELINEATIONHIPPOCAMPUS TARGET DELINEATION
HIPPOCAMPUS TARGET DELINEATION
 
PET-CT in Oncology
PET-CT in OncologyPET-CT in Oncology
PET-CT in Oncology
 
Perfusion MRI (DSC and DCE perfusion techniques) for radiology residents
Perfusion MRI (DSC and DCE perfusion techniques) for radiology residentsPerfusion MRI (DSC and DCE perfusion techniques) for radiology residents
Perfusion MRI (DSC and DCE perfusion techniques) for radiology residents
 
Image Guided Radiation Therapy (IGRT)
Image Guided Radiation Therapy (IGRT)Image Guided Radiation Therapy (IGRT)
Image Guided Radiation Therapy (IGRT)
 
introduction to Intensity modulated radiation therapy
introduction to Intensity modulated radiation therapyintroduction to Intensity modulated radiation therapy
introduction to Intensity modulated radiation therapy
 
Dose volume histogram
Dose volume histogramDose volume histogram
Dose volume histogram
 
Oncology imaging
Oncology imagingOncology imaging
Oncology imaging
 
PSMA pet ct scan
PSMA pet ct scanPSMA pet ct scan
PSMA pet ct scan
 
Radiotherapy for Prostate Cancer
Radiotherapy for Prostate CancerRadiotherapy for Prostate Cancer
Radiotherapy for Prostate Cancer
 
Srs and sbrt 2 dr.kiran
Srs and sbrt 2 dr.kiranSrs and sbrt 2 dr.kiran
Srs and sbrt 2 dr.kiran
 
4D Scan and Respiratory Gating
4D Scan and Respiratory Gating4D Scan and Respiratory Gating
4D Scan and Respiratory Gating
 
Cervix External Beam Radiotherapy techniques
Cervix External Beam Radiotherapy techniquesCervix External Beam Radiotherapy techniques
Cervix External Beam Radiotherapy techniques
 

Viewers also liked

Discussion on EnMS - PPT by Mr.Velan
Discussion on EnMS - PPT by Mr.VelanDiscussion on EnMS - PPT by Mr.Velan
Discussion on EnMS - PPT by Mr.Velan
mcci175
 
Richard smeltz linkedin presentation
Richard smeltz   linkedin presentationRichard smeltz   linkedin presentation
Richard smeltz linkedin presentation
Richard Smeltz
 
Gated heart pool scanning - breast uptake
Gated heart pool scanning  - breast uptakeGated heart pool scanning  - breast uptake
Gated heart pool scanning - breast uptake
todd_charge
 

Viewers also liked (20)

UACH Fisica en la Oncologia
UACH Fisica en la OncologiaUACH Fisica en la Oncologia
UACH Fisica en la Oncologia
 
Money
MoneyMoney
Money
 
DSS HORATIO SECURE CLOUD
DSS HORATIO SECURE CLOUDDSS HORATIO SECURE CLOUD
DSS HORATIO SECURE CLOUD
 
Reporting de performances de campagnes d'Ads Twitter - Olympia Bruno Coquatrix
Reporting de performances de campagnes d'Ads Twitter - Olympia Bruno CoquatrixReporting de performances de campagnes d'Ads Twitter - Olympia Bruno Coquatrix
Reporting de performances de campagnes d'Ads Twitter - Olympia Bruno Coquatrix
 
Discussion on EnMS - PPT by Mr.Velan
Discussion on EnMS - PPT by Mr.VelanDiscussion on EnMS - PPT by Mr.Velan
Discussion on EnMS - PPT by Mr.Velan
 
Who
WhoWho
Who
 
Eng
EngEng
Eng
 
Richard smeltz linkedin presentation
Richard smeltz   linkedin presentationRichard smeltz   linkedin presentation
Richard smeltz linkedin presentation
 
Lesson 22
Lesson  22Lesson  22
Lesson 22
 
Richard smeltz linkedin presentation
Richard smeltz   linkedin presentationRichard smeltz   linkedin presentation
Richard smeltz linkedin presentation
 
DSS Media Off Site Storage
DSS Media Off Site StorageDSS Media Off Site Storage
DSS Media Off Site Storage
 
DSS Horatio Secure Cloud
DSS Horatio Secure CloudDSS Horatio Secure Cloud
DSS Horatio Secure Cloud
 
Gated heart pool scanning - breast uptake
Gated heart pool scanning  - breast uptakeGated heart pool scanning  - breast uptake
Gated heart pool scanning - breast uptake
 
Customer service manifesto
Customer service manifestoCustomer service manifesto
Customer service manifesto
 
DSS Horatio Secure Cloud
DSS Horatio Secure CloudDSS Horatio Secure Cloud
DSS Horatio Secure Cloud
 
презентация1
презентация1презентация1
презентация1
 
Lietening text 演示文稿
Lietening text 演示文稿Lietening text 演示文稿
Lietening text 演示文稿
 
Filtration of radiopharmaceuticals by posidyne neo filters
Filtration of radiopharmaceuticals by posidyne neo filtersFiltration of radiopharmaceuticals by posidyne neo filters
Filtration of radiopharmaceuticals by posidyne neo filters
 
Brochure Horatio Secure Cloud
Brochure Horatio Secure CloudBrochure Horatio Secure Cloud
Brochure Horatio Secure Cloud
 
DSS Horatio Secure Cloud Plus
DSS Horatio Secure Cloud PlusDSS Horatio Secure Cloud Plus
DSS Horatio Secure Cloud Plus
 

Similar to SUV- standardised uptake values in pet scanning

19 440 Publication in NAUN journal
19 440 Publication in NAUN journal 19 440 Publication in NAUN journal
19 440 Publication in NAUN journal
Pawitra Masa-ah
 
Endpoint considerations in cancer clinical trials
Endpoint considerations in cancer clinical trials Endpoint considerations in cancer clinical trials
Endpoint considerations in cancer clinical trials
Bhaswat Chakraborty
 
Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
 Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons... Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
breastcancerupdatecongress
 
passive home based monitoring
passive home based monitoringpassive home based monitoring
passive home based monitoring
Bart de Witte
 
Jean Marc Nabholtz : Médicaments biologiques : Critères d’enregistrement et d...
Jean Marc Nabholtz : Médicaments biologiques : Critères d’enregistrement et d...Jean Marc Nabholtz : Médicaments biologiques : Critères d’enregistrement et d...
Jean Marc Nabholtz : Médicaments biologiques : Critères d’enregistrement et d...
breastcancerupdatecongress
 
Alan Garber: Value-Conscious Bio-Medical Innovation: Why? How? When?
Alan Garber:  Value-Conscious Bio-Medical Innovation:  Why?  How? When?Alan Garber:  Value-Conscious Bio-Medical Innovation:  Why?  How? When?
Alan Garber: Value-Conscious Bio-Medical Innovation: Why? How? When?
capstoneconference09
 
NY Prostate Cancer Conference - A. Vickers - Session 8: Debate 2: Categorical...
NY Prostate Cancer Conference - A. Vickers - Session 8: Debate 2: Categorical...NY Prostate Cancer Conference - A. Vickers - Session 8: Debate 2: Categorical...
NY Prostate Cancer Conference - A. Vickers - Session 8: Debate 2: Categorical...
European School of Oncology
 
Cancer Cervix- NACT vs RT+CCT
Cancer Cervix- NACT vs RT+CCTCancer Cervix- NACT vs RT+CCT
Cancer Cervix- NACT vs RT+CCT
Sheh Rawat
 

Similar to SUV- standardised uptake values in pet scanning (20)

19 440 Publication in NAUN journal
19 440 Publication in NAUN journal 19 440 Publication in NAUN journal
19 440 Publication in NAUN journal
 
Endpoint considerations in cancer clinical trials
Endpoint considerations in cancer clinical trials Endpoint considerations in cancer clinical trials
Endpoint considerations in cancer clinical trials
 
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
 
Optimizing Therapeutic Strategies in Castration-Resistant Prostate Cancer
Optimizing Therapeutic Strategies in Castration-Resistant Prostate CancerOptimizing Therapeutic Strategies in Castration-Resistant Prostate Cancer
Optimizing Therapeutic Strategies in Castration-Resistant Prostate Cancer
 
Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
 Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons... Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
 
Efficacy endpoints in Oncology
Efficacy endpoints in OncologyEfficacy endpoints in Oncology
Efficacy endpoints in Oncology
 
passive home based monitoring
passive home based monitoringpassive home based monitoring
passive home based monitoring
 
Oncotype dx
Oncotype dxOncotype dx
Oncotype dx
 
Jean Marc Nabholtz : Médicaments biologiques : Critères d’enregistrement et d...
Jean Marc Nabholtz : Médicaments biologiques : Critères d’enregistrement et d...Jean Marc Nabholtz : Médicaments biologiques : Critères d’enregistrement et d...
Jean Marc Nabholtz : Médicaments biologiques : Critères d’enregistrement et d...
 
Alan Garber: Value-Conscious Bio-Medical Innovation: Why? How? When?
Alan Garber:  Value-Conscious Bio-Medical Innovation:  Why?  How? When?Alan Garber:  Value-Conscious Bio-Medical Innovation:  Why?  How? When?
Alan Garber: Value-Conscious Bio-Medical Innovation: Why? How? When?
 
NY Prostate Cancer Conference - A. Vickers - Session 8: Debate 2: Categorical...
NY Prostate Cancer Conference - A. Vickers - Session 8: Debate 2: Categorical...NY Prostate Cancer Conference - A. Vickers - Session 8: Debate 2: Categorical...
NY Prostate Cancer Conference - A. Vickers - Session 8: Debate 2: Categorical...
 
A new Standard Uptake Values (SUV) Calculation based on Pixel Intensity Values
A new Standard Uptake Values (SUV) Calculation based on Pixel Intensity ValuesA new Standard Uptake Values (SUV) Calculation based on Pixel Intensity Values
A new Standard Uptake Values (SUV) Calculation based on Pixel Intensity Values
 
Recent advances in radiation oncology final (1)
Recent advances in radiation oncology  final (1)Recent advances in radiation oncology  final (1)
Recent advances in radiation oncology final (1)
 
Improve Outcome in Major Abdominal Surgery with ProAQT
Improve Outcome in Major Abdominal Surgery with ProAQTImprove Outcome in Major Abdominal Surgery with ProAQT
Improve Outcome in Major Abdominal Surgery with ProAQT
 
Cancer Cervix- NACT vs RT+CCT
Cancer Cervix- NACT vs RT+CCTCancer Cervix- NACT vs RT+CCT
Cancer Cervix- NACT vs RT+CCT
 
Adjuvant chemotherapy of breast cancer
Adjuvant chemotherapy of breast cancerAdjuvant chemotherapy of breast cancer
Adjuvant chemotherapy of breast cancer
 
Central Adiposity and Mortality after First-Ever Acute Ischemic Stroke
Central Adiposity and Mortality after First-Ever Acute Ischemic StrokeCentral Adiposity and Mortality after First-Ever Acute Ischemic Stroke
Central Adiposity and Mortality after First-Ever Acute Ischemic Stroke
 
Management of Metastatic Cancer Prostate
Management of Metastatic Cancer ProstateManagement of Metastatic Cancer Prostate
Management of Metastatic Cancer Prostate
 
D5 efficacy endpoints in oncology
D5   efficacy endpoints in oncologyD5   efficacy endpoints in oncology
D5 efficacy endpoints in oncology
 
Understanding and interpretation of patient reported outcomes
Understanding and interpretation of patient reported outcomesUnderstanding and interpretation of patient reported outcomes
Understanding and interpretation of patient reported outcomes
 

Recently uploaded

CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
ocean4396
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
claviclebrown44
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
palsonia139
 

Recently uploaded (20)

World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answers
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
PREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptxPREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptx
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
hypo and hyper thyroidism final lecture.pptx
hypo and hyper thyroidism  final lecture.pptxhypo and hyper thyroidism  final lecture.pptx
hypo and hyper thyroidism final lecture.pptx
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
 

SUV- standardised uptake values in pet scanning

  • 1. SUV’s - A Brief Overview of Silly Useless Values. Todd Charge Senior Technologist Nuclear Medicine and PET Centre Hunter Health Imaging Service Hunter Health Imaging Service
  • 2. Standardised Uptake Values Quantification has always held a pervasive allure for Nuclear Medicine. There is a sense that anything that can be quantified should be. J.W. Keyes Jr. PET Centre North Carolina USA Journal Nuclear Medicine 1995; 36:1836-1839 Hunter Health Imaging Service
  • 3. What are SUV’s?  A measure of FDG uptake as a function of time  Quantitative evaluation of tumour metabolism  Often used as a measure of malignancy vs. benignancy of lesion Hunter Health Imaging Service
  • 4. Standardised Uptake Value Data courtesy Mount Vernon Hospital Hunter Health Imaging Service
  • 5. Standardised Uptake Value Pre Treatment Post Treatment SUV = 18 SUV = 4 Hunter Health Imaging Service
  • 6. Standardised Uptake Value C /(T ) SUV = dose/bodyweight  Where C/(T) = FDG concentration in tissue at time T Hunter Health Imaging Service
  • 7. Standardised Uptake Value  Tracer concentration is usually determined from the image pixel that shows the highest lesion activity  Average concentration was once used but is not routinely in use now Hunter Health Imaging Service
  • 8. Assumptions of SUV’s  Negligible free FDG in tissue at time of PET scan  Equilibrium reached between plasma and free FDG in tissue  All tissues are affected in the same way by glucose levels Hunter Health Imaging Service
  • 9. Variables Influencing SUV’s  Large number of variables which need to be taken into account.  Patient size  Measurement times  Plasma Glucose  ROI  Partial Volume Effect  Camera specifications Hunter Health Imaging Service
  • 10. Summary  Use of Lean Body Mass instead of true weight  Take plasma glucose levels into account, tumour type & possible treatment effects  Standardise uptake time, attenuation correction, scatter correction and filtering  Consider ROI placement and use of max pixel Hunter Health Imaging Service
  • 11. Summary  Only use SUV within institution and even camera specific  Be careful when using SUV threshold to distinguish tumour from normal tissue  Consider SUV in conjunction with a subjective analysis of a lesion. Hunter Health Imaging Service
  • 12. Summary  Overall, recognise SUV’s for what they are: A helpful clue, but not the final answer. Hunter Health Imaging Service
  • 13. References  DiChiro G, Brooks RA. “PET quantitation: Blessing and Curse.” J Nucl Med 1988:29;1603-1604  S Meikle “Quantitative Methods and Factors Affecting SUV Calculation” ANZSNM PET Workshop 2003  JW Keyes “SUV: Standard Uptake or Silly Useless Value?” J Nucl Med 36:1836-1839, 1995 Hunter Health Imaging Service